RENERVE LIMITED - Announcements

0.00%

9.5¢

Market Cap $10.47M

Healthcare Medical Devices

ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve... ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve repair and regeneration solutions. The Company is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. It is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. It is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. It consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur. More

Announcements

Filter Results

All Price Sensitive Only

RNV	ReNerve - Corporate Governance Statement		29/08/25	314.53KB	Share
RNV	ReNerve - Appendix 4G		29/08/25	313.35KB	Share
RNV	ReNerve - Full Year Results		29/08/25	274.31KB	Share
RNV	ReNerve 2025 Annual Report		29/08/25	1.33MB	Share
RNV	ReNerve - Appendix 4E	PRICE SENSITIVE	29/08/25	114.67KB	Share
RNV	ReNerve records first sale of deep dermal product range	PRICE SENSITIVE	18/08/25	257.33KB	Share
RNV	Quarterly Investor Presentation		12/08/25	1.34MB	Share
RNV	Quarterly Investor Webinar		30/07/25	243.72KB	Share
RNV	Q4 FY25 Activities Report and Appendix 4C	PRICE SENSITIVE	30/07/25	518.43KB	Share
RNV	Cleansing Notice		14/07/25	212.92KB	Share
RNV	Application for quotation of securities - RNV		14/07/25	17.36KB	Share
RNV	Proposed issue of securities - RNV		11/07/25	14.81KB	Share
RNV	Investor presentation - the Berkeley Biologics Partnership		03/06/25	828.75KB	Share
RNV	Expands Product Portfolio with Berkley partnership / Webinar	PRICE SENSITIVE	02/06/25	279.61KB	Share
RNV	ReNerve receives market approval in Bahrain	PRICE SENSITIVE	28/05/25	241.75KB	Share
RNV	Change of Director's Interest Notice - S Cooper		09/05/25	22.46KB	Share
RNV	Quarterly Investor Presentation		07/05/25	1.92MB	Share
RNV	Notification regarding unquoted securities - RNV		30/04/25	29.89KB	Share
RNV	Quarterly Investor Webinar		29/04/25	147.37KB	Share
RNV	ReNerve - Q3 FY25 Activities Report & Appendix 4C	PRICE SENSITIVE	29/04/25	544.56KB	Share
RNV	Change in substantial holding		17/04/25	275.73KB	Share
RNV	Expands Global Footprint with Strategic Partnership in India	PRICE SENSITIVE	10/04/25	250.37KB	Share
RNV	Response to ASX Aware Letter	PRICE SENSITIVE	31/03/25	352.08KB	Share
RNV	Clinical Outcome Demonstrates Material Benefits for Patients	PRICE SENSITIVE	28/03/25	504KB	Share
RNV	Notification of cessation of securities - RNV		26/03/25	14.1KB	Share
RNV	Change of Director's Interest Notice - J Chick		20/03/25	24.46KB	Share
RNV	Cleansing Notice		14/03/25	163.18KB	Share
RNV	Application for quotation of securities - RNV		14/03/25	17.25KB	Share
RNV	Proposed issue of securities - RNV		13/03/25	14.81KB	Share
RNV	Marketing Approval in Thailand & Initial Sales in Hong Kong		11/03/25	260.34KB	Share
RNV	ReNerve Receives Additional $139K R&D Refund		07/03/25	171.78KB	Share
RNV	1HFY25 Results Announcement	PRICE SENSITIVE	28/02/25	196.31KB	Share
RNV	1HFY25 Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/25	504.88KB	Share
RNV	ReNerve enters distribution partnership in Mexico		27/02/25	268.09KB	Share
RNV	Change of Director's Interest Notice - M Panaccio		14/02/25	24.71KB	Share
RNV	Change of Director's Interest Notice - J Chick		10/02/25	24.31KB	Share
RNV	Quarterly Investor Presentation		06/02/25	1.62MB	Share
RNV	Investor Webinar Update		31/01/25	226.88KB	Share
RNV	ReNerve - Q2 FY25 Activities Report & Appendix 4C	PRICE SENSITIVE	29/01/25	850.17KB	Share
RNV	Becoming a substantial holder		09/01/25	124.11KB	Share
RNV	Change in substantial holding		18/12/24	177.57KB	Share
RNV	Change of Director's Interest Notice - S Cooper		18/12/24	4.15KB	Share
RNV	Change in substantial holding		17/12/24	177.48KB	Share
RNV	Change of Director's Interest Notice - S Cooper		17/12/24	4.15KB	Share
RNV	Change in substantial holding		13/12/24	587.34KB	Share
RNV	Change of Director's Interest Notice - J Chick		13/12/24	4.24KB	Share
RNV	Exclusive Partnership with Supplier in the Middle East	PRICE SENSITIVE	10/12/24	219.14KB	Share
RNV	Exclusive Partnership with Leading Distributor in Hong Kong	PRICE SENSITIVE	03/12/24	219.81KB	Share
RNV	ReNerve - Investor Presentation		02/12/24	3.6MB	Share
RNV	Becoming a substantial holder - Zetland Road Pty Ltd		26/11/24	1.23MB	Share
RNV	Becoming a substantial holder - Lucen Pty Ltd		26/11/24	1.72MB	Share
RNV	Commencement of Trading		26/11/24	144.14KB	Share
RNV	Initial Director's Interest Notice - Michael Panaccio		26/11/24	3.17KB	Share
RNV	Initial Director's Interest Notice - Stephen Cooper		26/11/24	3.03KB	Share
RNV	Initial Director's Interest Notice - David Rhodes		26/11/24	2.63KB	Share
RNV	Initial Director's Interest Notice - Julian Chick		26/11/24	3.18KB	Share
RNV	Becoming a substantial holder - Julian Chick		26/11/24	547.1KB	Share
RNV	Pre-quotation Disclosure Statement		22/11/24	61.88KB	Share
RNV	Top 20 Holders		22/11/24	84.43KB	Share
RNV	Distribution Schedule		22/11/24	69.27KB	Share
RNV	Trading Policy		22/11/24	171.35KB	Share
RNV	Corporate Governance Statement		22/11/24	271.69KB	Share
RNV	Employee Option Plan		22/11/24	212.82KB	Share
RNV	Annual Report - 30 June 2024		22/11/24	621.74KB	Share
RNV	Annual Report - 30 June 2023		22/11/24	379.43KB	Share
RNV	Constitution		22/11/24	594.1KB	Share
RNV	Replacement Prospectus		22/11/24	3.66MB	Share
RNV	Information Form and Checklist		22/11/24	245.04KB	Share
RNV	Appendix 1A		22/11/24	51.53KB	Share
RNV	Admission and Quotation		22/11/24	450.94KB	Share

RNV ReNerve - Corporate Governance Statement
29/08/25		314.53KB	Share
RNV ReNerve - Appendix 4G
29/08/25		313.35KB	Share
RNV ReNerve - Full Year Results
29/08/25		274.31KB	Share
RNV ReNerve 2025 Annual Report
29/08/25		1.33MB	Share
RNV ReNerve - Appendix 4E
29/08/25	PRICE SENSITIVE	114.67KB	Share
RNV ReNerve records first sale of deep dermal product range
18/08/25	PRICE SENSITIVE	257.33KB	Share
RNV Quarterly Investor Presentation
12/08/25		1.34MB	Share
RNV Quarterly Investor Webinar
30/07/25		243.72KB	Share
RNV Q4 FY25 Activities Report and Appendix 4C
30/07/25	PRICE SENSITIVE	518.43KB	Share
RNV Cleansing Notice
14/07/25		212.92KB	Share
RNV Application for quotation of securities - RNV
14/07/25		17.36KB	Share
RNV Proposed issue of securities - RNV
11/07/25		14.81KB	Share
RNV Investor presentation - the Berkeley Biologics Partnership
03/06/25		828.75KB	Share
RNV Expands Product Portfolio with Berkley partnership / Webinar
02/06/25	PRICE SENSITIVE	279.61KB	Share
RNV ReNerve receives market approval in Bahrain
28/05/25	PRICE SENSITIVE	241.75KB	Share
RNV Change of Director's Interest Notice - S Cooper
09/05/25		22.46KB	Share
RNV Quarterly Investor Presentation
07/05/25		1.92MB	Share
RNV Notification regarding unquoted securities - RNV
30/04/25		29.89KB	Share
RNV Quarterly Investor Webinar
29/04/25		147.37KB	Share
RNV ReNerve - Q3 FY25 Activities Report & Appendix 4C
29/04/25	PRICE SENSITIVE	544.56KB	Share
RNV Change in substantial holding
17/04/25		275.73KB	Share
RNV Expands Global Footprint with Strategic Partnership in India
10/04/25	PRICE SENSITIVE	250.37KB	Share
RNV Response to ASX Aware Letter
31/03/25	PRICE SENSITIVE	352.08KB	Share
RNV Clinical Outcome Demonstrates Material Benefits for Patients
28/03/25	PRICE SENSITIVE	504KB	Share
RNV Notification of cessation of securities - RNV
26/03/25		14.1KB	Share
RNV Change of Director's Interest Notice - J Chick
20/03/25		24.46KB	Share
RNV Cleansing Notice
14/03/25		163.18KB	Share
RNV Application for quotation of securities - RNV
14/03/25		17.25KB	Share
RNV Proposed issue of securities - RNV
13/03/25		14.81KB	Share
RNV Marketing Approval in Thailand & Initial Sales in Hong Kong
11/03/25		260.34KB	Share
RNV ReNerve Receives Additional $139K R&D Refund
07/03/25		171.78KB	Share
RNV 1HFY25 Results Announcement
28/02/25	PRICE SENSITIVE	196.31KB	Share
RNV 1HFY25 Appendix 4D and Half Year Report
28/02/25	PRICE SENSITIVE	504.88KB	Share
RNV ReNerve enters distribution partnership in Mexico
27/02/25		268.09KB	Share
RNV Change of Director's Interest Notice - M Panaccio
14/02/25		24.71KB	Share
RNV Change of Director's Interest Notice - J Chick
10/02/25		24.31KB	Share
RNV Quarterly Investor Presentation
06/02/25		1.62MB	Share
RNV Investor Webinar Update
31/01/25		226.88KB	Share
RNV ReNerve - Q2 FY25 Activities Report & Appendix 4C
29/01/25	PRICE SENSITIVE	850.17KB	Share
RNV Becoming a substantial holder
09/01/25		124.11KB	Share
RNV Change in substantial holding
18/12/24		177.57KB	Share
RNV Change of Director's Interest Notice - S Cooper
18/12/24		4.15KB	Share
RNV Change in substantial holding
17/12/24		177.48KB	Share
RNV Change of Director's Interest Notice - S Cooper
17/12/24		4.15KB	Share
RNV Change in substantial holding
13/12/24		587.34KB	Share
RNV Change of Director's Interest Notice - J Chick
13/12/24		4.24KB	Share
RNV Exclusive Partnership with Supplier in the Middle East
10/12/24	PRICE SENSITIVE	219.14KB	Share
RNV Exclusive Partnership with Leading Distributor in Hong Kong
03/12/24	PRICE SENSITIVE	219.81KB	Share
RNV ReNerve - Investor Presentation
02/12/24		3.6MB	Share
RNV Becoming a substantial holder - Zetland Road Pty Ltd
26/11/24		1.23MB	Share
RNV Becoming a substantial holder - Lucen Pty Ltd
26/11/24		1.72MB	Share
RNV Commencement of Trading
26/11/24		144.14KB	Share
RNV Initial Director's Interest Notice - Michael Panaccio
26/11/24		3.17KB	Share
RNV Initial Director's Interest Notice - Stephen Cooper
26/11/24		3.03KB	Share
RNV Initial Director's Interest Notice - David Rhodes
26/11/24		2.63KB	Share
RNV Initial Director's Interest Notice - Julian Chick
26/11/24		3.18KB	Share
RNV Becoming a substantial holder - Julian Chick
26/11/24		547.1KB	Share
RNV Pre-quotation Disclosure Statement
22/11/24		61.88KB	Share
RNV Top 20 Holders
22/11/24		84.43KB	Share
RNV Distribution Schedule
22/11/24		69.27KB	Share
RNV Trading Policy
22/11/24		171.35KB	Share
RNV Corporate Governance Statement
22/11/24		271.69KB	Share
RNV Employee Option Plan
22/11/24		212.82KB	Share
RNV Annual Report - 30 June 2024
22/11/24		621.74KB	Share
RNV Annual Report - 30 June 2023
22/11/24		379.43KB	Share
RNV Constitution
22/11/24		594.1KB	Share
RNV Replacement Prospectus
22/11/24		3.66MB	Share
RNV Information Form and Checklist
22/11/24		245.04KB	Share
RNV Appendix 1A
22/11/24		51.53KB	Share
RNV Admission and Quotation
22/11/24		450.94KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.5¢		Change 0.000(0.00%)		Mkt cap ! $10.47M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
8	87015	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	93265	2

View Market Depth

No.	Vol.	Price($)
8	87015	0.095
1	8000	0.093
1	50000	0.090
1	13902	0.072
0	0	0.000

Price($)	Vol.	No.
0.100	93265	2
0.110	20988	2
0.115	82463	4
0.120	101824	2
0.125	5000	1

Last trade - 16.21pm 05/09/2025 (20 minute delay)

RNV (ASX) Chart

Day chart unavailable

RENERVE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories